Staar Surgical Co. [STAA] stock is trading at $46.00, up 10.92%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The STAA shares have gain 3.32% over the last week, with a monthly amount glided 18.99%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Staar Surgical Co. [NASDAQ: STAA] stock has seen the most recent analyst activity on June 11, 2024, when BTIG Research upgraded its rating to a Buy but kept the price target unchanged to $46 for it. Previously, Stifel upgraded its rating to Buy on March 11, 2024, and elevated its price target to $50. On December 05, 2023, downgrade downgraded it’s rating to Hold. Morgan Stanley started tracking the stock assigning a Equal-Weight rating and suggested a price target of $35 on December 04, 2023. The Benchmark Company downgraded its rating to a Hold. Canaccord Genuity downgraded its rating to Hold for this stock on August 03, 2023, and downed its price target to $48. In a note dated June 07, 2023, William Blair downgraded an Mkt Perform rating on this stock.
Staar Surgical Co. [STAA] stock has fluctuated between $26.66 and $58.82 over the past year. Currently, Wall Street analysts expect the stock to reach $54.58 within the next 12 months. Staar Surgical Co. [NASDAQ: STAA] shares were valued at $46.00 at the most recent close of the market. An investor can expect a potential return of 18.65% based on the average STAA price forecast.
Analyzing the STAA fundamentals
Staar Surgical Co. [NASDAQ:STAA] reported sales of 326.24M for the trailing twelve months, which represents a growth of 5.21%. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at 0.08%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.04 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 41.28 points at the first support level, and at 36.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 48.41, and for the 2nd resistance point, it is at 50.82.
Ratios To Look Out For
For context, Staar Surgical Co.’s Current Ratio is 5.84. Also, the Quick Ratio is 5.22, while the Cash Ratio stands at 3.57. Considering the valuation of this stock, the price to sales ratio is 6.93, the price to book ratio is 5.75 and price to earnings (TTM) ratio is 148.72.
Transactions by insiders
Recent insider trading involved BROADWOOD PARTNERS, L.P., 10% Owner, that happened on May 09 ’24 when 1.0 shares were purchased. Director, WEISNER AIMEE S completed a deal on Mar 14 ’24 to buy 1750.0 shares. Meanwhile, 10% Owner BROADWOOD PARTNERS, L.P. bought 4042.0 shares on Jan 08 ’24.
